Department of Biochemistry
Edward N. Harris has not added Biography.
If you are Edward N. Harris and would like to personalize this page please email our Author Liaison for assistance.
Endocytic function, glycosaminoglycan specificity, and antibody sensitivity of the recombinant human 190-kDa hyaluronan receptor for endocytosis (HARE).
The Journal of biological chemistry Aug, 2004 | Pubmed ID: 15208308
Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE).
The Journal of biological chemistry Feb, 2007 | Pubmed ID: 17145755
The hyaluronan receptor for endocytosis mediates hyaluronan-dependent signal transduction via extracellular signal-regulated kinases.
The Journal of biological chemistry May, 2008 | Pubmed ID: 18387958
The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparin.
The Journal of biological chemistry Jun, 2008 | Pubmed ID: 18434317
The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E.
Glycobiology Aug, 2008 | Pubmed ID: 18499864
The cytoplasmic domain of the hyaluronan receptor for endocytosis (HARE) contains multiple endocytic motifs targeting coated pit-mediated internalization.
The Journal of biological chemistry Aug, 2008 | Pubmed ID: 18539600
Rat and human HARE/stabilin-2 are clearance receptors for high- and low-molecular-weight heparins.
American journal of physiology. Gastrointestinal and liver physiology Jun, 2009 | Pubmed ID: 19359419
N-Glycans on the link domain of human HARE/Stabilin-2 are needed for hyaluronan binding to purified ecto-domain, but not for cellular endocytosis of hyaluronan.
Glycobiology Aug, 2010 | Pubmed ID: 20466649
Probing structural selectivity of synthetic heparin binding to Stabilin protein receptors.
The Journal of biological chemistry Jun, 2012 | Pubmed ID: 22547069
The hyaluronan receptor for endocytosis (HARE) activates NF-κB-mediated gene expression in response to 40-400-kDa, but not smaller or larger, hyaluronans.
The Journal of biological chemistry May, 2013 | Pubmed ID: 23530033
Homogeneous low-molecular-weight heparins with reversible anticoagulant activity.
Nature chemical biology Apr, 2014 | Pubmed ID: 24561662
Tissue-specific splice variants of HARE/Stabilin-2 are expressed in bone marrow, lymph node, and spleen.
Biochemical and biophysical research communications Jan, 2015 | Pubmed ID: 25446080
In vivo selection to identify bacterial strains with enhanced ecological performance in synbiotic applications.
Applied and environmental microbiology Apr, 2015 | Pubmed ID: 25616794
HARE-Mediated Endocytosis of Hyaluronan and Heparin Is Targeted by Different Subsets of Three Endocytic Motifs.
International journal of cell biology , 2015 | Pubmed ID: 25883656
Interrogating Endogenous Protein Phosphatase Activity with Rationally Designed Chemosensors.
ACS chemical biology Jan, 2016 | Pubmed ID: 26580981
Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver.
Nucleic acids research Apr, 2016 | Pubmed ID: 26908652
Alcoholic vs non-alcoholic fatty liver in rats: distinct differences in endocytosis and vesicle trafficking despite similar pathology.
BMC gastroenterology Feb, 2016 | Pubmed ID: 26924554
Activation of ERK and NF-κB during HARE-Mediated Heparin Uptake Require Only One of the Four Endocytic Motifs.
PloS one , 2016 | Pubmed ID: 27100626
SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis.
BioMed research international , 2017 | Pubmed ID: 28293634
Antisense Oligonucleotides: Treatment Strategies and Cellular Internalization.
RNA & disease (Houston, Tex.) , 2016 | Pubmed ID: 28374018
Quantification of Cell Signaling Networks Using Kinase Activity Chemosensors.
Methods in molecular biology (Clifton, N.J.) , 2017 | Pubmed ID: 28730472
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유